StockNews.com lowered shares of Relx (NYSE:RELX – Free Report) from a buy rating to a hold rating in a report released on Tuesday.
Separately, Redburn Atlantic started coverage on shares of Relx in a research report on Wednesday, January 8th. They issued a “buy” rating on the stock.
Relx Stock Down 2.7 %
Relx Increases Dividend
The firm also recently declared a semi-annual dividend, which will be paid on Wednesday, June 25th. Shareholders of record on Friday, May 9th will be given a dividend of $0.5586 per share. This is a boost from Relx’s previous semi-annual dividend of $0.23. This represents a yield of 1.6%. The ex-dividend date is Friday, May 9th. Relx’s dividend payout ratio (DPR) is presently 59.68%.
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently bought and sold shares of RELX. Ameriprise Financial Inc. grew its position in Relx by 368.7% during the fourth quarter. Ameriprise Financial Inc. now owns 2,807,038 shares of the technology company’s stock valued at $127,437,000 after acquiring an additional 2,208,119 shares during the last quarter. Raymond James Financial Inc. bought a new position in Relx during the fourth quarter valued at approximately $44,516,000. Northern Trust Corp grew its position in Relx by 51.6% during the fourth quarter. Northern Trust Corp now owns 2,191,588 shares of the technology company’s stock valued at $99,542,000 after acquiring an additional 745,532 shares during the last quarter. Bank of Montreal Can boosted its stake in shares of Relx by 290.3% during the fourth quarter. Bank of Montreal Can now owns 886,758 shares of the technology company’s stock valued at $40,277,000 after purchasing an additional 659,547 shares during the period. Finally, Arrowstreet Capital Limited Partnership boosted its stake in shares of Relx by 50.3% during the fourth quarter. Arrowstreet Capital Limited Partnership now owns 1,968,739 shares of the technology company’s stock valued at $89,420,000 after purchasing an additional 658,655 shares during the period. 15.02% of the stock is currently owned by institutional investors.
Relx Company Profile
RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.
Featured Articles
- Five stocks we like better than Relx
- 10 Best Airline Stocks to Buy
- Investing in Small-Cap AI: Powering the Next Tech Revolution
- Growth Investing: Should You Adopt This Investing Strategy in 2022?
- Occidental Petroleum Drops to 52-Week Low: Buy, Sell, or Hold?
- How to Calculate Stock Profit
- Super Micro Computer Is Now NASDAQ Compliant—But Is It a Buy?
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.